Steven Mennen
About Steven Mennen
Steven Mennen serves as the Executive Director and Head of CMC at Fulcrum Therapeutics, bringing extensive experience in chemical process development and regulatory interactions. His background includes roles at Amgen and Abbott Laboratories, along with advanced degrees in Organic Chemistry from Yale University and Boston College.
Current Role at Fulcrum Therapeutics
Steven Mennen serves as the Executive Director and Head of CMC at Fulcrum Therapeutics, a position he has held since 2023. In this role, he oversees the chemistry, manufacturing, and controls (CMC) aspects of the company's operations. His responsibilities include managing the development of clinical trial protocols and ensuring compliance with quality management reviews. Mennen's expertise in CMC is critical for the advancement of therapeutic candidates within the organization.
Previous Experience at Fulcrum Therapeutics
Prior to his current role, Steven Mennen worked at Fulcrum Therapeutics in various capacities. He was the Senior Director and Head of CMC from 2021 to 2022 and served as the Director and Head of CMC from 2019 to 2021. During his tenure, he contributed significantly to the company's CMC strategies and operations, enhancing the development processes for therapeutic products.
Career Background at Amgen
Steven Mennen has an extensive background at Amgen, where he held multiple positions from 2009 to 2019. He worked as a Scientist in Chemical Process R&D from 2009 to 2014, and later as a Senior Scientist from 2014 to 2018. He also served as a Principal Scientist for one year in 2018-2019. His work at Amgen focused on the development of chemical processes and solid dosage forms, contributing to the advancement of various therapeutic programs.
Educational Qualifications
Steven Mennen has a strong academic background in Organic Chemistry. He completed his PhD at Boston College from 2002 to 2007 and further pursued a post-doctoral fellowship at UC Irvine from 2007 to 2009. Additionally, he studied at Yale University for one year in 2006-2007, where he also focused on Organic Chemistry. His educational achievements provide a solid foundation for his expertise in the pharmaceutical industry.
Expertise in Chemistry and Manufacturing
Steven Mennen possesses extensive knowledge in the synthesis of small molecules and solid oral dosage forms. He has experience with peptides, oligonucleotides, and parenteral delivery systems. Mennen is skilled in managing Contract Development and Manufacturing Organizations (CDMOs) and building global end-to-end CDMO supply chains. His interactions with global regulatory agencies on CMC filings further demonstrate his expertise in the field.